Moreover, our study uncovered the therapeutic potential of circNAB1 in LKB1‐deficient mice, a model of spontaneous AF development.[42] Delivery of circNAB1 effectively suppressed atrial fibrosis and inflammation in LKB1 KO mouse atriums. Here, STK11 is linked to fibrosis.